VIVIAN MORALES: Open Payments
NPI 1225716368 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 6 payments from 6 companies in 2025. Trend: 2023 $218 · 2024 $336 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, Auvelity, COBENFY, GARDASIL 9, PREVNAR 20, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
